A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Flurandrenolide
Sunitinib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Sunitinib.
Flurandrenolide
Posaconazole
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Posaconazole.
Flurandrenolide
Dasatinib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Dasatinib.
Flurandrenolide
Inotersen
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Inotersen.
Flurandrenolide
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Pipemidic acid.
Flurandrenolide
Rufloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Rufloxacin.
Flurandrenolide
Lidoflazine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Lidoflazine.
Flurandrenolide
Piromidic acid
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Piromidic acid.
Flurandrenolide
Lorajmine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Lorajmine.
Flurandrenolide
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Oxolinic acid.
Flurandrenolide
Prajmaline
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Prajmaline.
Flurandrenolide
Bencyclane
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Bencyclane.
Flurandrenolide
Cibenzoline
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Cibenzoline.
Flurandrenolide
Gallopamil
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Gallopamil.
Flurandrenolide
Cicletanine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Cicletanine.
Flurandrenolide
Pilsicainide
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Pilsicainide.
Flurandrenolide
Givinostat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Givinostat.
Flurandrenolide
Triclabendazole
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Triclabendazole.
Flurandrenolide
Temefos
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Temefos.
Flurandrenolide
Delafloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Delafloxacin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3